hotspot -WSS

hotspot

author：Wikipedia 2025-09-06 02:03:50 - browse：2

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： 7 more heat

WSS

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Judge rejects Trump's request to move Stormy Daniels hush

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

EF3 tornado rips through North Carolina amid extreme weather nationwide

Indian pharmaceutical industry in denial over drug

Do digital therapeutics have a future in medicine?

Wikipedia

hotspot

explore

As demand for Covid shots wanes, Moderna seeks its next success

Cognito secures funding to test medical device for Alzheimer's

Duchenne breakthrough therapy leaves behind pioneering families

The real point of Kenneth Smith’s execution by nitrogen gas

Psychedelics group wrestles with new pharma identity

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Medicare proposal to cover medical devices draws a mixed reaction

Cybersecurity threat forces Lurie Children's to take systems offline

Peter Hotez and the public health issue of online harassment

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

explore

Texas Department of Public Safety speaks out on migrant abuse allegations

SAMSHA loosens regulations on methadone treatment centers

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

FDA drug safety: Singulair case shows systemic surveillance flaws

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Quicker fix for pulse oximeters urged during FDA public meeting

focus

entertainment

Wikipedia

focus